Us Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market was valued at USD 1.5 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
US Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market: A Growing Trend in Eye Care
The US Non-steroidal Anti-inflammatory Drugs (NSAIDs) market for ophthalmology is witnessing rapid growth as the demand for effective treatments in the eye care sector escalates. Ophthalmic NSAIDs are gaining prominence due to their ability to reduce inflammation, alleviate pain, and aid in the post-operative recovery of patients undergoing eye surgeries such as cataract and LASIK procedures. The ongoing advancements in pharmaceutical research and the introduction of innovative formulations are expected to contribute significantly to market growth.
These drugs are primarily used to manage inflammation associated with eye conditions like allergic conjunctivitis, uveitis, and post-surgical inflammation. In addition to treating pain and inflammation, NSAIDs help in controlling post-operative complications such as cystoid macular edema, enhancing the recovery process for patients. A surge in eye-related surgeries and a growing number of elderly patients with age-related eye diseases are fueling the demand for NSAIDs in the ophthalmology market.
The increasing awareness of the benefits of NSAIDs in managing post-operative eye pain and inflammation is one of the key drivers for the market's expansion. Many patients seek alternatives to steroid-based treatments, which can have adverse effects when used long-term. This shift towards NSAIDs is expected to continue, as these drugs offer an effective, safer option for managing ocular inflammation without the risk of steroid-related side effects.
Key players in the US market are focusing on developing specialized NSAIDs tailored for ophthalmic use. Innovative products, such as preservative-free formulations and fixed-dose combinations, are helping cater to patient needs more effectively. The market also benefits from strategic collaborations between ophthalmic drug manufacturers and healthcare providers to improve drug accessibility and awareness.
As the demand for ophthalmic NSAIDs continues to grow, stakeholders in the healthcare sector are expected to capitalize on this trend. Moreover, similar to the booming “100 Gigabit Fiber Optic Transceiver Market,” this sector's development points to a growing recognition of specialized treatments in the healthcare space, where innovation is key to market success.
Get an In-Depth Research Analysis of the Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size And Forecast [2025-2032]
AbbVie
Bausch Health
Bayer
Dossa Pharmaceuticals
GlaxoSmithKline
Janssen Pharmaceuticals
Novartis
Pfizer
Sun Pharmaceutical Industries
Senju Pharmaceutical
Sichuan Heyi Pharmaceutical
Shandong Haishan Pharmaceutical
Guangdong Zhongsheng Pharmaceutical
Hangzhou Minsheng Pharmaceutical
Cisen Pharmaceutical
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market
COX-2 Inhibitors
Non-selective NSAIDs
Post-operative Inflammation
Ocular Pain Management
Uveitis
Conjunctivitis
Topical
Oral
Injectable
Hospitals
Ophthalmology Clinics
Ambulatory Surgical Centers
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Research Analysis
1. Introduction of the Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market, By Type
6. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market, By Application
7. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/